{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Lichfield&answer.answeringMemberConstituency=Mid+Norfolk&max-answer.dateOfAnswer=2022-05-26", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberConstituency=Lichfield&answer.answeringMemberConstituency=Mid+Norfolk&max-answer.dateOfAnswer=2022-05-26", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Lichfield&answer.answeringMemberConstituency=Mid+Norfolk&_metadata=all&max-answer.dateOfAnswer=2022-05-26", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&tablingMemberConstituency=Lichfield&answer.answeringMemberConstituency=Mid+Norfolk&max-answer.dateOfAnswer=2022-05-26", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Lichfield&answer.answeringMemberConstituency=Mid+Norfolk&max-answer.dateOfAnswer=2022-05-26", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Lichfield&answer.answeringMemberConstituency=Mid+Norfolk&max-answer.dateOfAnswer=2022-05-26", "items" : [{"_about" : "http://data.parliament.uk/resources/1399372", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1399372/answer", "answerText" : {"_value" : "<p>Recent analysis supports our understanding that the Pfizer/BioNTech and Moderna vaccines, which are currently being deployed in the UK, appear to work well against the current dominant variants of COVID-19 after a booster-dose. Continuing to administer these vaccines at scale remains essential in our path out of the pandemic.<\/p><p> <\/p><p>The Government continues to assess our existing vaccine portfolio against current variants, working closely with vaccine manufacturers and the UK Health Security Agency to understand the efficacy of our current vaccine portfolio against new variants.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2022-01-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-01-12T09:49:01.64Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2022-01-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what plans there are to manipulate the covid-19 vaccine to sensitise it to the omicron and other variants; and when he estimates such vaccines might become available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/280", "label" : {"_value" : "Biography information for Michael Fabricant"}
      }
      , "tablingMemberConstituency" : {"_value" : "Lichfield"}
      , "tablingMemberPrinted" : [{"_value" : "Michael Fabricant"}
      ], "uin" : "96760"}
    , {"_about" : "http://data.parliament.uk/resources/1356481", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1356481/answer", "answerText" : {"_value" : "<p>We are planning for all scenarios in the fight against COVID-19 and the\u202fVaccine Taskforce is taking a number of steps to ensure the UK is prepared to respond to current and emerging COVID-19 variants as quickly as possible.<\/p><p> <\/p><p>However, current data suggests that all deployed COVID-19 vaccines in the UK - AstraZeneca, Pfizer and Moderna -\u202foffer protection against the prevalent virus variants currently\u202fcirculating in the UK, and recent data indicates that the Pfizer vaccine remains effective against Beta variant.<\/p><p> <\/p><p>We continue to assess the efficacy of the vaccines currently in our portfolio\u202fagainst\u202fnew and future variants of the virus and continue to work closely with vaccine manufacturers to ensure that vaccines\u202fthat\u202fhave already received UK regulatory approval could be suitably updated, where possible and where needed, to remain effective against emerging variants of SARS-CoV-2.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
        }
        , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
        , "answeringMemberPrinted" : {"_value" : "George Freeman"}
        , "dateOfAnswer" : {"_value" : "2021-09-23", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-09-23T16:43:51.443Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2021-09-17", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what plans his Department has to acquire vaccines to provide protection from the most recent variants of covid-19; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/280", "label" : {"_value" : "Biography information for Michael Fabricant"}
      }
      , "tablingMemberConstituency" : {"_value" : "Lichfield"}
      , "tablingMemberPrinted" : [{"_value" : "Michael Fabricant"}
      ], "uin" : "50943"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}